SynthesisFrontiers in oncology2025
The rising influence of lipid metabolism in lung cancer: a global research perspective.
Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer is a prevalent malignant neoplasm globally and the leading cause of cancer-related mortality, posing a significant threat to human health and imposing a considerable societal burden. Researchers have recently focused more on lipid metabolism in lung cancer. However, to date, there has been no bibliometric analysis of lung cancer in relation to lipid metabolism. This study used bibliometric methods to analyze the link between lipid metabolism and lung cancer. Methods: Publications on lung cancer and lipid metabolism from 1995 to 2024 were sourced from the Web of Science Core Collection (WoSCC). The Microsoft Excel, R-bibliometrix, CiteSpace, and VOSviewer software were used to analyze and visualize the data. Results: In this study, a total of 535 publications were identified, with a marked increase in the number of publications observed post-2016. Both China and the United States exerted substantial influence in this domain. Notably, the Chinese Academy of Sciences and Huazhong University of Science and Technology have demonstrated leadership in various aspects of lipid metabolism research related to lung cancer. Professor Ana Ramirez de Molina and Conclusions: Research on the relationship between lung cancer and lipid metabolism was still in its early stages. Targeting lipid metabolism in lung cancer represented a promising therapeutic strategy, as inhibiting key enzymes involved in lipid biosynthesis and uptake has the potential to impede cancer progression and mitigate drug resistance. This bibliometric study was the first to thoroughly summarize research trends and developments in this area over the past thirty years, providing scholars with updated insights and identifying future research directions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.